Electrochemical behaviour of Venlafaxine and its determination in pharmaceutical products using square wave voltammetry

被引:30
作者
Lima, JLFC [1 ]
Loo, DV [1 ]
Delerue-Matos, C [1 ]
da Silva, ASR [1 ]
机构
[1] Univ Porto, Fac Farm, Dept Quim Fis, CEQUP, P-4050 Porto, Portugal
来源
FARMACO | 1999年 / 54卷 / 03期
关键词
venlafaxine; voltammetry; pharmaceutical formulations;
D O I
10.1016/S0014-827X(99)00007-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
An electrochemical method for the determination of Venlafaxine in pharmaceutical formulations recently available on the European market is described. The electrochemical oxidation of Venlafaxine was studied at a HMDE electrode over a wide pH range (1.9-10.0) of buffered aqueous solutions using different potential sweep techniques. The results obtained showed that the best definition of the analytical signals was found in boric acid/potassium tetrahydroxoborate buffer at pH 8.7 using anodic stripping square wave voltammetry. Recovery trials were performed to assess the accuracy of results and these were compared to those provided by a HPLC technique according to the method described in literature and to the features of the pharmaceutical formulations. A relative deviation of < 0.2% was obtained. With the developed methodology, the limit of detection was 0.124 mg/l. (C) 1999 Elsevier Science S.A. All rights reserved.
引用
收藏
页码:145 / 148
页数:4
相关论文
共 6 条
[1]   VENLAFAXINE - A HETEROCYCLIC ANTIDEPRESSANT [J].
ELLINGROD, VL ;
PERRY, PJ .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (24) :3033-3046
[2]   PREPARATION OF UNIVERSAL BUFFER WITH IONIC-STRENGTH 0.3M [J].
FERNANDEZ, CM ;
MARTIN, VC .
TALANTA, 1977, 24 (12) :747-748
[3]   A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS DETERMINATION OF VENLAFAXINE AND O-DESMETHYLVENLAFAXINE IN BIOLOGICAL-FLUIDS [J].
HICKS, DR ;
WOLANIUK, D ;
RUSSELL, A ;
CAVANAUGH, N ;
KRAML, M .
THERAPEUTIC DRUG MONITORING, 1994, 16 (01) :100-107
[4]   CLINICAL UTILITY OF VENLAFAXINE IN COMPARISON WITH OTHER ANTIDEPRESSANTS [J].
LECRUBIER, Y .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 :29-35
[6]  
MONTGOMERY SA, 1995, INT CLIN PSYCHOPHARM, V10, P22